Age (in years) |
Frequency |
Percentage |
30 - 39 |
4 |
2.5 |
40 - 49 |
21 |
13.1 |
50 - 59 |
62 |
38.8 |
60 - 69 |
30 |
18.8 |
>= 70 |
43 |
26.9 |
Sex | Frequency | Percentage |
Male | 139 | 86.9 |
Female | 21 | 13.1 |
Total | 160 | 100 |
History of smoking |
Frequency |
Percentage |
Non smoker |
18 |
11.3 |
50 - 200 |
13 |
8.1 |
200 - 500 |
21 |
13.1 |
500 - 1000 |
65 |
40.6 |
> 1000 |
43 |
26.9 |
Comorbidity |
Frequency |
Percentage |
COPD |
93 |
58 |
Anaemia |
80 |
50 |
PulmonaryTB(Treated/Untreated) |
32 |
20 |
Asthma |
5 |
3 |
Family History of Ca(GIT) |
3 |
2 |
CAD |
10 |
6 |
Histology |
Frequency |
Percentage |
Squamous cell carcinoma |
46 |
28.8 |
Adino carcinoma |
67 |
41.9 |
Small cell carcinoma |
26 |
16.3 |
Large cell carcinoma |
4 |
2.5 |
Non-specific |
17 |
10.6 |
|
TNM |
Frequency |
Percentage |
Stage I |
3 |
1.9 |
Stage II |
22 |
13.8 |
Stage IIIa |
15 |
9.4 |
Stage IIIb |
21 |
13.1 |
Stage IV |
49 |
30.6 |
Limited stage |
5 |
3.1 |
Extensive stage |
22 |
13.8 |
Stage unknown |
23 |
14.4 |
Sex |
Sqamous cell
carcinoma |
Adenocarcinoma |
Small cell
carcinoma |
Large cell
carcinoma |
Non specific |
Male |
42 (91.3%) |
50 (74.6%) |
26 (100%) |
4 (100%) |
17 (100%) |
Female |
4 (8.7%) |
17 (25.4%) |
|
|
|
Smoking |
Squamous
Cell Carcinoma |
Adino
Carcinoma |
Small Cell
Carcinoma |
Large Cell
Carcinoma |
Non-specific |
Non Smoker |
4 |
14 |
- |
- |
- |
|
8.70% |
20.90% |
|
|
|
50-200 |
2 |
9 |
2 |
- |
- |
|
4.30% |
13.40% |
7.70% |
|
|
200 – 500 |
5 |
16 |
- |
- |
- |
|
10.90% |
23.90% |
|
|
|
500-1000 |
11 |
17 |
20 |
4 |
13 |
|
23.90% |
25.40% |
76.90% |
100% |
76.50% |
> 1000 |
24 |
11 |
4 |
- |
4 |
|
52.20% |
16.40% |
15.40% |
|
23.50% |
Chi square: 68.574; p
<0.001 |
Treatment |
Frequency |
Percentage |
Surgery + Chemotherapy |
8 |
5 |
Chemotherapy + Radiotherapy |
152 |
95 |